Postal survey of bronchoscopic practice by physicians in the United Kingdom.

Abstract

In 1983 a postal survey of the bronchoscopic practice of chest physicians in the United Kingdom produced a 90% response rate. Two hundred and thirty one physicians were carrying out bronchoscopy; they had performed about 40 000 bronchoscopies in the preceding year, 87% of these being fibreoptic procedures with topical anaesthesia. The mortality rate of fibreoptic bronchoscopy was 0.04%, with a 0.12% incidence of major complications. Transbronchial biopsy carried both an appreciably higher mortality rate of 0.12% and a major complication rate of 2.7%. There is wide variation in the use and choice of sedative drugs for fibreoptic bronchoscopy. Many of the drug combinations could be criticised on pharmacological grounds. The mean dose of lignocaine was 342 mg, most operators exceeding the usual maximum recommended dose; but adverse reactions were rare. Routine supplemental oxygen was given by only 18% of bronchoscopists. Basic resuscitation equipment was often inadequate. Radiological screening was used for transbronchial lung biopsy by 53% of respondents and significantly reduced the incidence of pneumothorax from 2.9% to 1.8%. Both the number of bronchoscopies performed and the complication rate were higher than previous estimates. Bronchoscopists should re-examine their policy on drugs and safety precautions to minimise the risks of the procedure.

Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient

“…9 With the inclusion of TBB these rates rise to 0.12% and 2.7%, respectively. However, when looking at the high-risk immunosuppressed oncology population the complication rate rises to between 5% and 15% 8,10 with the much higher complication rates in those having TBB due mainly to bleeding.…”

Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer

“…1,24 In addition, some patients with NSCLC will have contraindications to endobronchial biopsy. 25 The management of advanced NSCLC remains an issue of great importance. The results from a national survey of patients with NSCLC in the United States demonstrated that 67.2% of patients had stage III/IV disease, and [33% of patients with NSCLC received multimodality treatment, which consisted most commonly of chemotherapy and radiotherapy.…”

Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983

“…First, fibreoptic bronchoscopy became more widely available (Simpson et al, 1986), and second, chemotherapy was established as first-line treatment for patients with small cell lung cancer (MRC Lung Cancer Working Party, 1979).…”